login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ABBVIE INC (ABBV) Stock News
NYSE:ABBV -
US00287Y1091
-
Common Stock
210.6
USD
+1.1 (+0.53%)
Last: 8/22/2025, 8:04:00 PM
210.6
USD
0 (0%)
After Hours:
8/22/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ABBV Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Chartmill
- Mentions:
EL
LULU
TPL
SCHW
...
These S&P500 stocks are moving in today's session
19 hours ago - By: The Motley Fool
- Mentions:
BRK
SHOP
ORCL
3 Top Stocks to Build Your Portfolio Around
2 days ago - By: The Motley Fool
- Mentions:
PFE
ABT
3 Unstoppable Dividend Stocks to Buy Right Now
2 days ago - By: Yahoo Finance
- Mentions:
PFE
ABT
3 Unstoppable Dividend Stocks to Buy Right Now
2 days ago - By: Yahoo Finance
- Mentions:
ALDX
JonesTrading Lifts Aldeyra Therapeutics, Inc. (ALDX) Price Target to $9
3 days ago - By: Zacks Investment Research
- Mentions:
PFE
LLY
INCY
AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth
3 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
MRK
ABBV's Improving Oncology Sales Poise It Well for Long-Term Growth
3 days ago - By: Zacks Investment Research
- Mentions:
XOM
The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil and AbbVie
3 days ago - By: Zacks Investment Research
- Mentions:
XOM
CEG
PWR
MKL
Top Stock Reports for Alphabet, Exxon Mobil & AbbVie
4 days ago - By: Benzinga
A Congress Member Bought Up To $1.17M In AbbVie Stock: Here's What You Need To Know
4 days ago - By: AbbVie
AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ®) for Alopecia Areata
5 days ago - By: Zacks Investment Research
- Mentions:
BMY
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
5 days ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
AbbVie Rises 11.5% in a Month: Buy, Hold or Sell the Stock?
6 days ago - By: Zacks Investment Research
- Mentions:
AZN
SOPH
TEM
Strategic Partnerships Power Tempus AI's Healthcare Expansion
6 days ago - By: AbbVie
AbbVie Completes Acquisition of Capstan Therapeutics
7 days ago - By: Zacks Investment Research
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
7 days ago - By: Yahoo Finance
- Mentions:
ABT
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today
10 days ago - By: Benzinga
Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today
13 days ago - By: AbbVie
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.
15 days ago - By: Yahoo Finance
- Mentions:
COST
UBER
My 3 Favorite Stocks to Buy Right Now
16 days ago - By: Yahoo Finance
- Mentions:
ABT
JNJ
3 Stocks Retirees Should Absolutely Love
Please enable JavaScript to continue using this application.